Pharma News, 2020

Headline results for the second quarter.

Unhappy with the price and availability of Gilead’s remdesivir—the only drug with FDA clearance to treat COVID-19—dozens of state attorney generals have called for the federal government to exer...

Scientists at Sanford Burnham Prebys Medical Discovery Institute have uncovered a novel drug target, a protein called PPP1R1B, that stops the deadly spread of pancreatic cancer, called metastasis, whe...

A study from FutureBrand found that the perception of pharma and healthcare companies improved since the beginning of the COVID-19 pandemic.

Your immune system's 'memory' T cells keep track of the viruses they have seen before.

Janssen has received US Food and Drug Administration (FDA) approval for its Spravato (esketamine) CIII nasal spray, in combination with an oral antidepressant, to treat depressive symp...

MUNICH/BERLIN (Reuters) - German health group Siemens Healthineers (SHLG.

SYDNEY, July 30 (Xinhua) -- Many dementia patients suffer the loss of ability to form memory, and now a new treatment tested on mice has shown that memory loss associated with Alzheimer's ...

PARIS (Reuters) - Healthcare company Sanofi Aventis France said it had been placed under formal investigation on charges of manslaughter over Depakine, which is an epilepsy drug that caused bi...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a green light for a Phase I trial assessing Celltrion's potential COVID-19 treatment CT-P59.

Janssen's Stelara (ustekinumab) has been approved in the US as a treatment for paediatric patients (six-11 years of age) who struggle with the skin lesions or plaques associated wi...

Gilead is part of a long list of drugmakers that have suffered from business slowdowns caused by COVID-19.